Found 165 matching trials
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque PHASE4 Vitamin K-antagonists (VKA) such as warfarin are the most widely used blood...
Show More Location
Los Angeles Biomedical Research Institute
Learn More & Join Trial
Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation PHASE4 Endothermal heat-induced thrombosis (EHIT) is a thrombotic complication spe...
Show More Location
Heart Artery and Vein Center of Fresno
Learn More & Join Trial
Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data N/A Investigators are building an empirical evidence base for real world data t...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Anticoagulation in Patients With Venous Thromboembolism and Cancer N/A This study is a retrospective analysis of observational cohorts using data ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis PHASE4 This trial aims to compare the safety and efficacy of apixaban alone versus...
Show More Location
Multiple Locations
Learn More & Join Trial
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy PHASE4 The study goal is to determine the clinical benefit of percutaneous cathete...
Show More Location
Charité Universitätsmedizin Berlin, Klinik für Kardiologie, Angiologie und Intensivmedizin, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin (CBF)
Learn More & Join Trial
Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment PHASE3 The aim of this trial is to find out if a tablet called apixaban can reduce...
Show More Location
University of Birmingham
Learn More & Join Trial
Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban NA Apixaban is a potent, oral, selective reversible direct inhibitor of factor...
Show More Location
Department of Cardiology Lariboisiere Hospital
Learn More & Join Trial
Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants PHASE3 The purpose of this study is to evaluate the safety of a protocol which doe...
Show More Location
Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Learn More & Join Trial
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy PHASE2 The study will evaluate the incidence of major bleeding (including clinical...
Show More Location
University of Southern California Keck School of Medicine
Learn More & Join Trial